Gallium [ga-67]-Citraat Curium

Gallium (67ga) Citrate is a diagnostic radiopharmaceutical used in imaging procedures to detect certain conditions. This intravenous medication is manufactured by Curium Belgium BV and is intended for medical imaging purposes.

Gallium (67ga) Citrate is primarily used in nuclear medicine for imaging studies. It helps in identifying areas of inflammation, infection, or certain types of tumors. This radiopharmaceutical is administered intravenously and is designed to assist healthcare professionals in diagnosing and monitoring specific medical conditions.

Gallium (67ga) Citrate works by binding to certain proteins in the body, which can then be detected through imaging techniques. This process helps in visualizing areas of interest, such as inflammation or abnormal growths. The effects are typically observed through specialized imaging equipment.

As with any radiopharmaceutical, Gallium (67ga) Citrate should be handled with care. It is important to follow proper safety protocols to minimize exposure to radiation. Pregnant women and individuals with known allergies to gallium compounds should consult their healthcare provider before use.

Gallium (67ga) Citrate may interact with other medications or substances. It is advisable to inform your healthcare provider about all current medications and supplements before undergoing imaging with this radiopharmaceutical. Specific interactions should be discussed with a medical professional.